Price of biologic drugs often too high for poor

By law, there is no way for other companies to make their own versions of biologicals, which are in a different category from standard drugs because they come from living cells. Health reform advocates want to change that. But the pharmaceutical industry is pushing back ferociously with a $66 million lobbying campaign to protect $46 billion in annual profits. It's a pivotal fight in the overall...